The Role of APOBEC3B in Lung Tumor Evolution and Targeted Cancer Therapy Resistance

Scientists studied the impact of the apolipoprotein B mRNA-editing catalytic subunit-like (APOBEC) enzyme APOBEC3B on epidermal growth factor receptor-driven lung cancer.